Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Alankrita Taneja's interest lie in hematological malignancies including lymphoma and multiple myeloma, with a special interest in cellular therapies. She also did a course in global and urban health equity while in residency and she is interested in health disparities and equitable care.

For more information, visit https://www.roswellpark.org/alankrita-taneja 

Blood Cancer OncTalk 2023 / Series number 5
Leading oncologists come together to discuss emerging treatment options and data regarding blood cancer, including multiple myeloma and lymphoma.
Author
Alankrita Taneja, Guest Faculty
Image
Blood Cancer OncTalk 2023

This is the third batch of videos from the Blood Cancer OncTalk playlist. In these videos, Dr. Alankrita Taneja defines Smoldering Multiple Myeloma (SMM) and discusses how it differs from Multiple Myeloma (MM), risk factors and treatments.

 

To watch the complete playlist click here.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora

Forum Discussions

I don't know what to do. No insurance

Hi Ascardino, Welcome to Grace. I'm so sorry to hear of your situation.  While we don't have specific info or expertise on ovarian cancer, I did some searching for information.  It...

Recent Comments

JOIN THE CONVERSATION
Hi Ascardino, Welcome to…
By JanineT GRACE … on
I don't know what to do. No…
By Ascardino on
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on